Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Pharmacyclics PCYC-1134M-CA: informCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia
Brief Description  
Primary: Describe current treatment patterns in the real-world setting of CLL patients who are initiating treatment with novel therapies including oral kinase inhibitors or other approved anti-CLL therapies/ regimens as 1st or later line of therapy. Explore association with baseline characteristics, healthcare resource utilization and clinical outcomes. Secondary: Characterize adverse events (AEs) ain CLL patients in this setting. Assess patient reported HRQOL and association with therapeutic
Who may be Eligible  
Please contact us for eligibility criteria.
Leukemia, not otherwise specified
Start Date  
Principal Investigator  
Ghosh, Nilanjan
Contact Name  
Kathryn Marrogy

For More Information, Contact  Kathryn  , Marrogy
Phone:  980-442-2343 Fax:    
Email:  kathryn.marrogy@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204